Approaching Drug Choices and Challenges for the Management of Hypertension. [PDF]
Bress AP, Luther JM.
europepmc +1 more source
Corrigendum to "Synergistic catalytic effect between ultrasound waves and pyrimidine-2,4-diamine-functionalized magnetic nanoparticles: Applied for synthesis of 1,4-dihydropyridine pharmaceutical derivatives" [Ultrason. Sonochem. 59 (2019) 104737]. [PDF]
Taheri-Ledari R, Rahimi J, Maleki A.
europepmc +1 more source
Targeting the US21 viroporin of human cytomegalovirus by calcium channel blockers as a new antiviral strategy. [PDF]
Sibille G +9 more
europepmc +1 more source
Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future. [PDF]
Halațiu VB, Cozac DA, Scridon A.
europepmc +1 more source
Transition metal-free hydrogenative coupling of nitroarenes mediated with dihydropyridine: chemoselective formation of aromatic azoxy, azo, hydrazine and phenazine. [PDF]
Lu C +6 more
europepmc +1 more source
Efficient and sustainable nanocatalyst based on dithiocarbamate ionic liquid functionalized magnetic graphene oxide for green synthesis of 1,4-dihydropyridins. [PDF]
Ghorbannia R, Baharfar R, Maleki B.
europepmc +1 more source
Outcomes of Calcium-Channel Blocker Use in Patients With Multiple Myeloma: A Propensity-Matched Study From the Global Federated Health Research Network. [PDF]
Eidbo S +7 more
europepmc +1 more source
Coexistence of Coronary Artery Ectasia and Myocardial Bridging: A Case Report. [PDF]
Jawad MJ +4 more
europepmc +1 more source
BRASH syndrome: a systematic review of clinical manifestations and associated risk factors. [PDF]
Tomulescu SA +9 more
europepmc +1 more source
The single Fe atoms and DDQ catalyst system for the aerobic dehydrogenation of dihydropyridines and dihydroquinazolinones. [PDF]
Veisi H, Rostami A.
europepmc +1 more source

